Heming Wu

Nanjing Medical University

Papers

1

Total Citations

5

H-Index

1

About

Heming Wu is a clinical researcher whose work sits at the intersection of advanced neuroimaging and precision neurosurgical diagnostics. His primary focus is on improving the diagnosis of primary central nervous system lymphoma (PCNSL), a challenging condition where accurate tissue sampling is critical. Wu’s most notable contribution is his pioneering application of multimodal imaging combined with frameless robotic stereotactic biopsy. In his landmark 2022 study, he demonstrated how integrating advanced imaging techniques with robotic precision can significantly enhance diagnostic yield for PCNSL. This work, which has garnered early citations from peers, offers a less invasive and more accurate alternative to traditional biopsy methods. By refining the workflow for suspected PCNSL cases, Wu is helping to reduce surgical risks and improve patient outcomes. His research bridges the gap between cutting-edge imaging technology and clinical neurosurgery, marking him as an emerging leader in neuro-oncological diagnostics. For students and researchers, Wu’s work exemplifies how technological integration can solve real-world clinical challenges in brain tumor diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Preliminary clinical application of multimodal imaging combined with frameless robotic stereotactic biopsy in the diagnosis of primary central nervous system lymphoma
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Nanjing Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago